AbbVie Total Liabilities & Equity increased by 1.9% to $136.46B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.2%, from $136.17B to $136.46B. Over 5 years (FY 2020 to FY 2025), Total Liabilities & Equity shows a downward trend with a -2.3% CAGR.
Growth in this figure indicates the expansion of the company's asset base through debt or equity financing.
This metric represents the sum of all liabilities and shareholders' equity, which must equal the total assets of the com...
A fundamental accounting identity used to verify the balance sheet across all sectors.
total_liabilities_and_equity| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $147.97B | $148.86B | $146.53B | $143.21B | $143.19B | $141.33B | $138.81B | $134.54B | $135.37B | $136.22B | $134.71B | $148.87B | $141.94B | $143.42B | $135.16B | $136.17B | $137.18B | $133.90B | $133.96B | $136.46B |
| QoQ Change | — | +0.6% | -1.6% | -2.3% | -0.0% | -1.3% | -1.8% | -3.1% | +0.6% | +0.6% | -1.1% | +10.5% | -4.7% | +1.0% | -5.8% | +0.7% | +0.7% | -2.4% | +0.0% | +1.9% |
| YoY Change | — | — | — | — | -3.2% | -5.1% | -5.3% | -6.1% | -5.5% | -3.6% | -2.9% | +10.7% | +4.9% | +5.3% | +0.3% | -8.5% | -3.4% | -6.6% | -0.9% | +0.2% |